| Nodrog vs Heihachi | 15–31 | 32.61% |
| Nodrog vs Reina | 17–17 | 50.00% |
| Nodrog vs Kazuya | 5–24 | 17.24% |
| Nodrog vs Bryan | 10–16 | 38.46% |
| Nodrog vs Jun | 9–16 | 36.00% |
| Nodrog vs Armor King | 4–21 | 16.00% |
| Nodrog vs Jin | 11–13 | 45.83% |
| Nodrog vs Steve | 9–13 | 40.91% |
| Nodrog vs King | 10–10 | 50.00% |
| Nodrog vs Azucena | 8–12 | 40.00% |
| Nodrog vs Lili | 8–11 | 42.11% |
| Nodrog vs Lidia | 8–11 | 42.11% |
| Nodrog vs Law | 4–14 | 22.22% |
| Nodrog vs Nina | 3–13 | 18.75% |
| Nodrog vs Hwoarang | 4–11 | 26.67% |
| Nodrog vs Lars | 5–9 | 35.71% |
| Nodrog vs Yoshimitsu | 7–5 | 58.33% |
| Nodrog vs Claudio | 5–7 | 41.67% |
| Nodrog vs Clive | 5–6 | 45.45% |
| Nodrog vs Asuka | 2–8 | 20.00% |
| Nodrog vs Lee | 7–2 | 77.78% |
| Nodrog vs Leroy | 5–4 | 55.56% |
| Nodrog vs Zafina | 2–6 | 25.00% |
| Nodrog vs Eddy | 3–5 | 37.50% |
| Nodrog vs Devil Jin | 1–6 | 14.29% |
| Nodrog vs Alisa | 3–4 | 42.86% |
| Nodrog vs Paul | 2–4 | 33.33% |
| Nodrog vs Victor | 4–2 | 66.67% |
| Nodrog vs Jack-8 | 1–4 | 20.00% |
| Nodrog vs Dragunov | 1–4 | 20.00% |
| Nodrog vs Raven | 2–3 | 40.00% |
| Nodrog vs Xiaoyu | 0–4 | 0.00% |
| Nodrog vs Shaheen | 2–2 | 50.00% |
| Nodrog vs Kuma | 0–4 | 0.00% |
| Nodrog vs Leo | 1–2 | 33.33% |
| Nodrog vs Fahkumram | 0–3 | 0.00% |
| Nodrog vs Feng | 0–2 | 0.00% |
| Nodrog vs Panda | 2–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.